title: Polymorphisms in the innate immune IFIH1 gene, frequency of enterovirus in monthly fecal samples during infancy, and islet autoimmunity.
abstract: Interferon induced with helicase C domain 1 (IFIH1) senses and initiates antiviral activity against enteroviruses. Genetic variants of IFIH1, one common and four rare SNPs have been associated with lower risk for type 1 diabetes. Our aim was to test whether these type 1 diabetes-associated IFIH1 polymorphisms are associated with the occurrence of enterovirus infection in the gut of healthy children, or influence the lack of association between gut enterovirus infection and islet autoimmunity.After testing of 46,939 Norwegian newborns, 421 children carrying the high risk genotype for type 1 diabetes (HLA-DR4-DQ8/DR3-DQ2) as well as 375 children without this genotype were included for monthly fecal collections from 3 to 35 months of age, and genotyped for the IFIH1 polymorphisms. A total of 7,793 fecal samples were tested for presence of enterovirus RNA using real time reverse transcriptase PCR.We found no association with frequency of enterovirus in the gut for the common IFIH1 polymorphism rs1990760, or either of the rare variants of rs35744605, rs35667974, rs35337543, while the enterovirus prevalence marginally differed in samples from the 8 carriers of a rare allele of rs35732034 (26.1%, 18/69 samples) as compared to wild-type homozygotes (12.4%, 955/7724 samples); odds ratio 2.5, p = 0.06. The association was stronger when infections were restricted to those with high viral loads (odds ratio 3.3, 95% CI 1.3-8.4, p = 0.01). The lack of association between enterovirus frequency and islet autoimmunity reported in our previous study was not materially influenced by the IFIH1 SNPs.We conclude that the type 1 diabetes-associated IFIH1 polymorphisms have no, or only minor influence on the occurrence, quantity or duration of enterovirus infection in the gut. Its effect on the risk of diabetes is likely to lie elsewhere in the pathogenic process than in the modification of gut infection.
authors: Norwegian Institute of Public Health, Oslo, Norway. elisabet.witso@gmail.com
authors: Elisabet
authors: E
authors: Witsø
authors: German
authors: G
authors: Tapia
authors: Ondrej
authors: O
authors: Cinek
authors: Flemming Michael
authors: FM
authors: Pociot
authors: Lars C
authors: LC
authors: Stene
authors: Kjersti S
authors: KS
authors: Rønningen
mesh_terms: D015551:Autoimmunity / Q000235:genetics*; D016022:Case-Control Studies; D015331:Cohort Studies; D053487:DEAD-box RNA Helicases / Q000235:genetics*; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology / Q000821:virology; D004770:Enterovirus / Q000302:isolation & purification* / Q000472:pathogenicity / Q000502:physiology; D005243:Feces / Q000821:virology*; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics*; D007223:Infant; D000072640:Interferon-Induced Helicase, IFIH1; D007422:Intestines / Q000276:immunology / Q000821:virology; D007515:Islets of Langerhans / Q000276:immunology* / Q000821:virology; D020641:Polymorphism, Single Nucleotide; D013997:Time Factors; D019562:Viral Load / Q000235:genetics
chemical_list: C452815:IFIH1 protein, human; D053487:DEAD-box RNA Helicases; D000072640:Interferon-Induced Helicase, IFIH1